Derivatives of amide analogs of certain methano bridged quinolizines
CA 2070573 C · Owner: Merrell Pharmaceuticals Inc. · Inventors: Gittos, Maurice W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to novel amide derivatives of certain hexahydro-8-hydroxy-2,6-methano-2H-quinolizine-type compounds. to the intermediates and processes for their preparation, to their ability to induce a blockage of 5HT3 receptors, and to their end-use application in the treatment of chemotherapeutically-induced nausea and vomiting as anti-anxiety agents, in the symptomatic treatment of pain associated with migraine, as anti-arrhythmic agents in the treatment of cognitive disorders in treating, hallucinatory endogenous psychoses of the type manifested in patients suffering from schizophrenia and mania, in the, treatment of glaucoma far stimulating gastric motility, to, combat drug …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 1992 and granted April 15, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 5, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.